Why do women fare worse than men after acute coronary syndromes?

European Journal of Internal Medicine

Volumn 13, Issue 8, 2002, Pages 471-473

  Falger, Paul R J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SERTRALINE; SIMVASTATIN;

ACUTE HEART INFARCTION; AGE DISTRIBUTION; ANXIETY DISORDER; BODY WEIGHT; BREAST CANCER; CARDIOTOXICITY; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY STENT; DEPRESSION; DIET; DRUG CONTRAINDICATION; EDITORIAL; EXERCISE; FEMALE; FEMALE GENITAL SYSTEM; HEART REHABILITATION; HOSPITALIZATION; HUMAN; INCIDENCE; MORBIDITY; MORTALITY; OUTPATIENT; PANIC; PSYCHOLOGICAL ASPECT; SEX DIFFERENCE; SMOKING CESSATION; SOCIAL ISOLATION; SOCIAL STATUS; SURVIVAL RATE; TREATMENT PLANNING; UNSTABLE ANGINA PECTORIS;

EID: 0036890630     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00161-9     Document Type: Editorial

References (35)

1. Fetters J.K., Peterson E.D., Shaw L.J., Newby L.K., Califf R.M. Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: have they been adequately evaluated? Am. Heart J. 131:1996;796-813.
2. Vaccarino V., for the National Registry of Myocardial Infarction 2 Participants . Sex-based differences in early mortality after myocardial infarction. New Engl. J. Med. 341:1999;217-225.
3. Hochman J.S., for the Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes iib Investigators . Sex, clinical presentation, and outcome in patients with acute coronary syndromes. New Engl. J. Med. 341:1999;226-232.
4. Brezinka V., Kittel F. Psychosocial factors of coronary heart disease in women: a review. Soc. Sci. Med. 42:1995;1351-1365.
5. Hemingway H., Marmot M. Psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. Br Med J. 318:1999;1460-1467.
6. Douglas P.S., Ginsburg G.S. The evaluation of chest pain in women. New Engl. J. Med. 334:1996;1311-1315.
7. Ayanian J.Z., Epstein A.M. Differences in the use of procedures between women and men hospitalized for coronary heart disease. New Engl. J. Med. 325:1991;221-225.
8. Steingart R.M., for the Survival and Ventricular Enlargement Investigators . Sex differences in the management of coronary artery disease. New Engl. J. Med. 325:1991;226-230.
9. Karcioglu Ö, Ünal Aslan B, Aslan Ö. Gender differences in the management and survival of patients with acute myocardial infarction. Eur J Intern Med 2002;13.
10. EUROASPIRE Study Group . EUROASPIRE, A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur. Heart. J. 18:1997;1569-1582.
11. Missouris C., Kalaitzidis R., Parchure N., Ziakka S., Ward D., Singer D. Coronary heart disease in the statin and aspirine era: are results of clinical trials being put into practice? Eur. J. Intern. Med. 12:2001;490-495.
12. Falger P.R.J. If cardiac patients benefit from statins, why not commonly prescribe them and follow up their use? Eur. J. Intern. Med. 12:2001;475-476. editorial.
13. The Scandinavian Simvastatin Survival Study Group . Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 344:1994;1383-1389.
14. Savoie I., Kazanjian A. Utilization of lipid-lowering drugs in men and women: a reflection of the research evidence? J Clin Epidemiol. 55:2002;95-101.
15. Applegate W.B. Elderly patients' adherence to statin therapy. J Am Med Assoc. 288:2002;495-497. editorial.
16. Van Hees L., McGee H., Dugmore L. The Carinex Survey. Current guidelines and practices in cardiac rehabilitation within Europe. 1999;Acco, Leuven.
17. Linden W., Stossel C., Maurice J. Psychosocial interventions for patients with coronary artery disease. A meta-analysis. Arch. Intern. Med. 156:1996;745-752.
18. Dusseldorp E., van Elderen T., Maes S., Meulman J., Kraaij V. A meta-analysis of psychoeducational programs for coronary heart disease patients. Health Psychol. 18:1999;506-519.
19. Donker F.J.S. Cardiac rehabilitation: A review of current developments. Clin Psychol Rev. 20:2000;923-943.
20. Sebregts E.H.W.J., Falger P.R.J., Bär F.W.H.M. Risk factor modification through non-pharmacological interventions in patients with coronary heart disease. J Psychosom Res. 48:2000;425-441.
21. Cooper A., Lloyd G., Weinman J., Jackson G. Why patients do not attend cardiac rehabilitation: role of intentions and illness beliefs. Heart. 82:1999;234-236.
22. Horsten M., Mittleman M.A., Wamala S.P., Schenck-Gustafsson K., Orth-Gomér K. Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. Eur Heart J. 21:2000;1072-1080.
23. Linden W. Psychological treatments in cardiac rehabilitation: Review of rationales and outcomes. J Psychosom Res. 48:2000;443-454.
24. Lane D., Carroll D., Ring C., Beevers D.G., Lip G.Y.H. Predictors of attendance at cardiac rehabilitation after myocardial infarction. J Psychosom Res. 51:2001;497-501.
25. Bankier B., Littman A.B. Psychiatric disorders and coronary heart disease in women - a still neglected topic: review of the literature from 1971 to 2000. Psychother Psychosom. 71:2002;133-140.
26. Denollet J., Brutsaert D.L. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation. 97:1998;167-173.
27. Orth-Gomér K., Horsten M., Wamala S.P., Mittleman M.A. Social relations and extent and severity of coronary artery disease: the Stockholm Female Coronary Risk Study. Eur Heart J. 19:1998;1648-1656.
28. Rozanski A., Blumenthal J.A., Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 99:1999;2192-2217.
29. Frasure-Smith N., Lespérance F., Talajic M. The impact of negative emotions on prognosis following myocardial infarction: Is it more than depression? Health Psychol. 14:1995;388-398.
30. Lane D., Carroll D., Ring C., Beevers D.G., Lip G.Y.H. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol. 7:2002;11-21.
31. Lane D., Carroll D., Ring C., Beevers D.G., Lip G.Y.H. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med. 63:2001;221-230.
32. Lespérance F., Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J Psychosom Res. 48:2000;379-391.
33. Glassman A.H., for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group . Sertraline treatment of major depression in patients with acute M.I. or unstable angina. J Am Med Assoc. 288:2002;701-709.
34. Schneiderman N. ENRICHED: basic design, primary outcomes, and secondary analyses of medical endpoints. Int J Behav Med 2002;9, Suppl 1:242. (abstract).
35. Saab P. ENRICHD: secondary analyses of psychosocial treatment, demographic and medical variables. Int J Behav Med 2002;9, Suppl 1:230. (abstract).